Pfizer COVID-19 Vaccine Produces Less Antibodies Against Delta Variant Of Coronavirus, Finds Study Published In Lancet
German Company BioNTech To Build First mRNA Manufacturing Facility In Singapore
Pfizer To Supply Its Covid-19 Vaccine Only Through Government Channels In India: Report
Pfizer-BioNTech Covid-19 Vaccine Effective Against Highly Infectious Coronavirus Variant Discovered In UK, Finds Study
First Adverse Reaction Of Pfizer & BioNTech's COVID-19 Vaccine Recorded In Finland
'Covid-19 Virus Will Stay With Us For Next Ten Years': BioNTech CEO
Covid Vaccine 'Highly Likely' To Work On UK Variant, Can Adapt It In 6 Weeks To Tackle New Strain If Needed: BioNTech CEO
Pfizer And BioNTech SE To Seek Emergency Use Approval From US FDA For Covid-19 Vaccine
Covid-19 Vaccine Developed By Pfizer-BioNTech Offers 90 Per Cent Protection Against Coronavirus Infection
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 Participants
A Tale Of Three Potential Vaccines – How They Stack Up In The Race For Coronavirus Prevention
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
